- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT05366933
B-Complex: Nutraceutyczny środek zaradczy SANS
In this project, the investigators propose to test effectiveness of a daily nutraceutical supplement containing bioactive B vitamins to mitigate optic disc edema in astronauts. The proposed countermeasure is intended to maximize functioning of the one-carbon metabolic pathway to provide enough substrate and cofactors to overcome any genetic differences that may impact the efficiency of enzyme function. By optimizing the pathway, this will 1) optimize endothelial function by increasing eNOS coupling and nitric oxide synthesis and 2) optimize collagen firmness and elasticity in the sclera and lamina cribrosa, and 3) minimize changes in total retinal thickness during and after flight.
The protocol includes assessments of ocular health and function, along with determinants of vascular endothelial function, advanced glycation end products, and nutritional status and one carbon biochemistry. These additional measures will be critical for the further definition of the causes of optic disc edema in some astronauts after long-duration space flight, and in understanding the effect of the countermeasure. Finally, the supplemented subjects in this study will be compared against total retinal thickness data from previously flown astronauts known to have not taken supplements during their missions.
Przegląd badań
Status
Interwencja / Leczenie
Szczegółowy opis
Fasting (8-h) blood samples (7.5 mL SST and 5 mL EDTA tubes, 12.5 mL total per session) will be collected approximately 180 days and 45 days before flight, and return to Earth +0-2 days and 30 days after landing.
Blood samples will be analyzed for vitamin status and one-carbon biochemistry, as previously described. One blood sample (collected before flight) will be analyzed for approximately 511 SNPs matching the profile of testing from our ongoing research related to optic disc edema. Serum samples will be analyzed for biochemistry measures evaluating endothelial function, vitamin status, and oxidative damage.
Nutritional status assessment data, including inflight dietary intake and body mass data, completed for routine medical requirements will be requested for data sharing. Inflight medical exercise log data as well as available standard measures data will also be requested for data sharing. Medication use/Med Logs will also be requested for data sharing.
Vascular function VENDYS-II (Endothelix, Inc) will be used to assess reactive hyperaemia through changes in fingertip temperature. The test consists of an automated blood pressure measurement followed by cuff occlusion of the right arm for 2 to 5 min. During this time, the fingertip temperature in the right hand decreases because of the lack of circulation in the fingertip. After the cuff is released, blood flow resumes, causing a temperature rebound in the fingertip in a manner that is proportional to vascular reactivity.
Advanced Glycation End (AGE) Products Skin autofluorescence (SAF) will be analyzed non-invasively using an AGE reader (Diagnoptics Technologies, Groningen, the Netherlands). The AGE reader illuminates a skin surface of approximately 4 cm2, guarded against surrounding light, with an excitation light source with wavelength between 300 and 429 nm. This method is based on the fluorescent properties of certain AGEs accumulated in dermal tissue.
OCT and OCT-A Optical coherence tomography (OCT) and OCT-angiography (OCT-A) scans will be acquired using the Spectralis OCT2 (Heidelberg Engineering) before, during, and after flight. The scan pattern includes 24 B-scans centered in a radial pattern over the optic nerve head, as well as a 3.5 mm circle scan surrounding the optic nerve head for assessment of retinal nerve fiber layer thickness and choroid thickness. For OCT-A, five consecutive volume scans will be obtained in these regions, each containing 216 A-scans. These images will be registered, and the consecutive B-scans will be used to calculate the decorrelation among the images to provide split-spectrum amplitude decorrelation angiography (SSADA) images. This decorrelation between consecutive B-scan images will be used to highlight locations where there is blood flow. The density of the perfused peripapillary vessels within the various layers of the retina will be calculated to create a flow density map.
Typ studiów
Zapisy (Szacowany)
Faza
- Faza 1
Kontakty i lokalizacje
Kontakt w sprawie studiów
- Nazwa: Sara Zwart, PhD
- Numer telefonu: 2814833753
- E-mail: sara.zwart-1@nasa.gov
Kopia zapasowa kontaktu do badania
- Nazwa: Eden Fields
- Numer telefonu: 2814837864
- E-mail: eden.e.fields@nasa.gov
Lokalizacje studiów
-
-
Texas
-
Houston, Texas, Stany Zjednoczone, 77058
- Rekrutacyjny
- Johnson Space Center
-
Kontakt:
- Eden Fields
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion Criteria:
• Must be astronauts selected for 6-12 month missions on the International Space Station
Exclusion Criteria:
• Subjects taking B-vitamin supplements
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Zapobieganie
- Przydział: Nie dotyczy
- Model interwencyjny: Zadanie dla jednej grupy
- Maskowanie: Brak (otwarta etykieta)
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
|---|---|
|
Eksperymentalny: Supplemented with B-Complex
Subjects will take a vitamin B-complex supplement before, during, and after a 6-12 month spaceflight on the International Space Station |
Vitamin B-Complex Supplement containing: 5-methyltetrahydrofolate, riboflavin 5 phosphate, pyridoxal phosphate, and methylcobalamin |
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Optic Disc Edema
Ramy czasowe: 6 months
|
Measure change in total retinal thickness during and after flight compared to preflight using OCT |
6 months
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Endothelial function
Ramy czasowe: 6 months
|
Assess reactive hyperemia through changes in fingertip temperature |
6 months
|
|
Advanced Glycation End Products (AGE)
Ramy czasowe: 6 months
|
Skin autofluorescence (SAF) will be analyzed non-invasively using an AGE reader |
6 months
|
|
Serum folate status
Ramy czasowe: 6 months
|
Vitamin status assessed from a fasting blood sample |
6 months
|
|
Red Blood Cell folate status
Ramy czasowe: 6 months
|
Vitamin status assessed from a fasting blood sample |
6 months
|
|
Vitamin B6 status
Ramy czasowe: 6 months
|
Vitamin status assessed from a fasting blood sample |
6 months
|
|
Vitamin B12 status
Ramy czasowe: 6 months
|
Vitamin status assessed from a fasting blood sample |
6 months
|
|
Glucose
Ramy czasowe: 6 months
|
Serum glucose from a fasting blood sample |
6 months
|
|
Nitric oxide
Ramy czasowe: 6 months
|
Serum nitric oxide from a fasting blood sample |
6 months
|
|
tetrahydrobiopterin
Ramy czasowe: 6 months
|
Serum biochemistry from a fasting blood sample |
6 months
|
|
Dihydrobiopterin
Ramy czasowe: 6 months
|
Serum biochemistry from a fasting blood sample |
6 months
|
|
Oxidized glutathione
Ramy czasowe: 6 months
|
Serum biochemistry from a fasting blood sample |
6 months
|
|
Total antioxidant capacity
Ramy czasowe: 6 months
|
Serum biochemistry from a fasting blood sample |
6 months
|
|
Advanced glycation end products
Ramy czasowe: 6 months
|
Serum biochemistry from a fasting blood sample |
6 months
|
|
Albumin
Ramy czasowe: 6 months
|
Serum biochemistry from a fasting blood sample |
6 months
|
|
Glycated albumin
Ramy czasowe: 6 months
|
Serum biochemistry from a fasting blood sample |
6 months
|
|
3-nitrotyrosine
Ramy czasowe: 6 months
|
Serum biochemistry from a fasting blood sample |
6 months
|
|
Formate
Ramy czasowe: 6 months
|
Serum biochemistry from a fasting blood sample |
6 months
|
|
MMP-2
Ramy czasowe: 6 months
|
Serum biochemistry from a fasting blood sample |
6 months
|
|
MMP-9
Ramy czasowe: 6 months
|
Serum biochemistry from a fasting blood sample |
6 months
|
|
TIMP-1
Ramy czasowe: 6 months
|
Serum biochemistry from a fasting blood sample |
6 months
|
|
TIMP-2
Ramy czasowe: 6 months
|
Serum biochemistry from a fasting blood sample |
6 months
|
|
Heparan sulfate
Ramy czasowe: 6 months
|
Serum biochemistry from a fasting blood sample |
6 months
|
|
Syndecan-1
Ramy czasowe: 6 months
|
Serum biochemistry from a fasting blood sample |
6 months
|
|
Glypican
Ramy czasowe: 6 months
|
Serum biochemistry from a fasting blood sample |
6 months
|
|
Hyaluronan
Ramy czasowe: 6 months
|
Serum biochemistry from a fasting blood sample |
6 months
|
|
Total lipid peroxides
Ramy czasowe: 6 months
|
Serum biochemistry from a fasting blood sample |
6 months
|
Współpracownicy i badacze
Śledczy
- Główny śledczy: Sara R Zwart, PhD, UTMB
Publikacje i pomocne linki
Publikacje ogólne
- Zwart SR, Laurie SS, Chen JJ, Macias BR, Lee SMC, Stenger M, Grantham B, Carey K, Young M, Smith SM. Association of Genetics and B Vitamin Status With the Magnitude of Optic Disc Edema During 30-Day Strict Head-Down Tilt Bed Rest. JAMA Ophthalmol. 2019 Oct 1;137(10):1195-1200. doi: 10.1001/jamaophthalmol.2019.3124.
- Zwart SR, Gibson CR, Gregory JF, Mader TH, Stover PJ, Zeisel SH, Smith SM. Astronaut ophthalmic syndrome. FASEB J. 2017 Sep;31(9):3746-3756. doi: 10.1096/fj.201700294. Epub 2017 May 25.
- Smith SM, Zwart SR. Spaceflight-related ocular changes: the potential role of genetics, and the potential of B vitamins as a countermeasure. Curr Opin Clin Nutr Metab Care. 2018 Nov;21(6):481-488. doi: 10.1097/MCO.0000000000000510.
- McGregor HR, Lee JK, Mulder ER, De Dios YE, Beltran NE, Kofman IS, Bloomberg JJ, Mulavara AP, Smith SM, Zwart SR, Seidler RD. Ophthalmic changes in a spaceflight analog are associated with brain functional reorganization. Hum Brain Mapp. 2021 Sep;42(13):4281-4297. doi: 10.1002/hbm.25546. Epub 2021 Jun 9.
- Laurie SS, Vizzeri G, Taibbi G, Ferguson CR, Hu X, Lee SMC, Ploutz-Snyder R, Smith SM, Zwart SR, Stenger MB. Effects of short-term mild hypercapnia during head-down tilt on intracranial pressure and ocular structures in healthy human subjects. Physiol Rep. 2017 Jun;5(11):e13302. doi: 10.14814/phy2.13302.
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Rzeczywisty)
Zakończenie podstawowe (Szacowany)
Ukończenie studiów (Szacowany)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Rzeczywisty)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- NASA IRB STUDY00000448
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .